Latest Articles

  • Quality, frailty, and common sense
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 777; DOI: https://doi.org/10.3949/ccjm.78b.11012

    Ideal management of the frail elder with severe congestive heart failure is not always a matter of devices and drugs.

  • In reply: Dabigatran (October 2011)
    Siddharth A. Wartak, MD and John R. Bartholomew, MD, FACC
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 787; DOI: https://doi.org/10.3949/ccjm.78c.12002
  • In reply: The negative U wave in the setting of demand ischemia (August 2011)
    Sridhar Venkatachalam, MD, MRCP and Curtis M. Rimmerman, MD, MBA
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 785; DOI: https://doi.org/10.3949/ccjm.78c:12004
  • Essential tremor: Choosing the right management plan for your patient
    Essential tremor: Choosing the right management plan for your patient
    Hesham Abboud, MD, Anwar Ahmed, MD and Hubert H. Fernandez, MD
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 821-828; DOI: https://doi.org/10.3949/ccjm.78a.10178

    Successful management entails excluding secondary causes, carefully selecting drug therapy, and, in severe resistant or atypical cases, referring to a specialist.

  • Dabigatran (October 2011)
    Van Smith, MD, FACP
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 787; DOI: https://doi.org/10.3949/ccjm.78c.12001

    Readers comment on negative U waves (August 2011) and on dabigatran (October 2011).

  • Bioidentical hormone therapy: Clarifying the misconceptions
    Lynn Pattimakiel, MD, NCMP and Holly L. Thacker, MD, FACP, NCMP
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 829-836; DOI: https://doi.org/10.3949/ccjm.78a.10114

    Many women are turning to bioidentical hormone therapy on the basis of misconceptions, which we hope to clarify.

  • A 25-year-old man with very high alkaline phosphatase
    Jamak Modaresi Esfeh, MD, Ibrahim A. Hanouneh, MD and Nizar N. Zein, MD
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 793-800; DOI: https://doi.org/10.3949/ccjm.78a.10166

    He has generalized malaise, a palpably enlarged liver, and an alkaline phosphatase level of 1,307 U/L. What is the cause?

  • Correction
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 787; DOI: https://doi.org/10.3949/ccjm.78c.12005
  • The negative U wave in the setting of demand ischemia (August 2011)
    Promporn Suksaranjit, MD, Wisit Cheungpasitporn, MD, Edward F. Bischof, MD and Herbert Marx, MD
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 785; DOI: https://doi.org/10.3949/ccjm.78c:12003

    Readers comment on negative U waves (August 2011) and on dabigatran (October 2011).

  • Index to Volume 78
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 780-784;

Pages